| PEMOA37 | Vaccine scheme, age and previous COVID-19 predict humoral response to SARS-CoV-2 vaccination in HIV-infected indivudals | Poster exhibition | SARS-Cov2 vaccines |
| PEMOA38 | People living with HIV who are receiving suppressive antiretroviral therapy mount strong humoral responses to two and three doses of COVID-19 vaccine | Poster exhibition | SARS-Cov2 vaccines |
| EPA083 | Evidence of recurrent selection of mutations commonly found in SARS-CoV-2 variants of concern in viruses infecting immunocompromised patients | E-poster | SARS-Cov2 Viral origins, evolution and diversity |
| EPC229 | Seasonality and male circumcision: an analysis of quarterly PEPFAR-supported voluntary medical male circumcisions for HIV prevention, 2016 ' 2019 | E-poster | Scale up of medical male circumcision |
| EPC230 | Timing for maximum anesthetic effect of topical cream during early infant male circumcision (EIMC) in Rakai, Uganda | E-poster | Scale up of medical male circumcision |
| EPC231 | Strengthening safety through surveillance: notifiable adverse events in the U.S. President's Emergency Plan for AIDS Relief's voluntary medical male circumcision program through 2020 | E-poster | Scale up of medical male circumcision |
| EPC232 | Real-world impact of male circumcision on HIV seroprevalence in sub-Saharan Africa: a household fixed-effects analysis among 279,351 men from 29 countries | E-poster | Scale up of medical male circumcision |
| EPC233 | Knowledge, attitude and perception of uninitiated adolescents towards customary male initiation practices in selected schools in Buffalo City Municipality, Eastern Cape | E-poster | Scale up of medical male circumcision |
| EPC234 | District-level coverage and unmet need for medical and traditional circumcision among men aged 10-29 years in sub-Saharan Africa | E-poster | Scale up of medical male circumcision |
| EPC225 | Trends in HIV post-exposure prophylaxis following sexual exposure (PEPSE) in Brazil (2011-2019) | E-poster | Scale up of PEP |